propargylglycine has been researched along with metallothionein in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cherian, MG; Gallant, KR | 1 |
Cherian, MG; Imura, N; Satoh, M; Shimizu, H | 1 |
Imura, N; Naganuma, A | 1 |
Cherian, MG; Chin, JL; Imura, N; Kadhim, SA; Kloth, DM; Naganuma, A; Satoh, M | 1 |
Cherian, MG; Satoh, M; Shibuya, K | 1 |
Haga, A; Kito, H; Nagase, H; Sato, T | 1 |
Choi, CH; Chung, MH; Jeong, JH; Kim, HS; Kim, MS; Kweon, OS; Lee, TB; Lim, DY; Min, YD; Rha, HS; You, HJ | 1 |
Hashimoto, H; Iwata, T; Saga, Y; Tokumitsu, M; Yachiku, S | 1 |
8 other study(ies) available for propargylglycine and metallothionein
Article | Year |
---|---|
Metabolic changes in glutathione and metallothionein in newborn rat liver.
Topics: Alkynes; Animals; Animals, Newborn; Buthionine Sulfoximine; Cysteine; Female; gamma-Glutamyltransferase; Glutathione; Glycine; Liver; Metallothionein; Methionine Sulfoximine; Pargyline; Pregnancy; Rats; Zinc | 1989 |
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibrosarcoma; Glycine; Humans; Male; Melphalan; Metallothionein; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Pargyline; Sulfates; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Zinc Compounds; Zinc Sulfate | 1994 |
[Role of metallothionein in cancer chemotherapy].
Topics: Alkynes; Animals; Antineoplastic Agents; Bismuth; Cisplatin; Drug Resistance; Female; Glycine; Lung Neoplasms; Melphalan; Metallothionein; Mice; Neoplasms, Experimental; Pargyline | 1994 |
Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Cystathionine gamma-Lyase; Drug Resistance; Female; Glutathione; Glycine; Kidney; Metallothionein; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Pargyline; Sulfates; Urinary Bladder Neoplasms; Zinc; Zinc Sulfate | 1993 |
Sensitivity to radiation treatment and changes in metallothionein synthesis in a transplanted murine tumor.
Topics: Alkynes; Animals; Enzyme Inhibitors; Fibrosarcoma; Glycine; Male; Metallothionein; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Radiotherapy Dosage; X-Rays; Zinc Sulfate | 1997 |
Inhibition effect of propargylglycine on human fibrosarcoma HT-1080 cell invasiveness.
Topics: Alkynes; Cadmium; Chemotaxis; Collagen; Copper; Dose-Response Relationship, Drug; Drug Combinations; Fibronectins; Fibrosarcoma; Glycine; Humans; Laminin; Metallothionein; Neoplasm Invasiveness; Platinum; Proteoglycans; Time Factors; Tumor Cells, Cultured | 1998 |
Reactive oxygen species-specific mechanisms of drug resistance in paraquat-resistant acute myelogenous leukemia sublines.
Topics: Alkynes; Antineoplastic Agents; Camptothecin; Cell Survival; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Glutathione Transferase; Glycine; Humans; Leukemia, Myeloid, Acute; Metallothionein; Paraquat; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase; Tumor Cells, Cultured; Vincristine | 2000 |
Reversal of acquired cisplatin resistance by modulation of metallothionein in transplanted murine tumors.
Topics: Alkynes; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cisplatin; Cystathionine gamma-Lyase; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Glutathione; Glycine; Injections, Intraperitoneal; Metallothionein; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Urinary Bladder Neoplasms | 2004 |